BioNTech SE (BNTX) EBT (2018 - 2025)

BioNTech SE (BNTX) has 8 years of EBT data on file, last reported at -$264.7 million in Q4 2025.

• In Q4 2025, EBT fell 182.24% year-over-year to -$264.7 million; the TTM figure through Dec 2025 stood at -$1.2 billion (down 58.48% YoY), while the FY2025 annual figure was -$1.2 billion, down 63.94% from the prior year.
• EBT fell to -$264.7 million in Q4 2025, from $28.9 million in the prior quarter.
• Across five years, EBT topped out at $5.6 billion in Q1 2022 and bottomed at -$867.8 million in Q2 2024.
• A 5-year average of $1.5 billion and a median of $517.7 million in 2023 frame the typical range for EBT.
• Annual changes were most pronounced in 2021 — EBT jumped 2199836406.41% — and 2025, when it slumped 182.24%.
• Year by year, EBT stood at $5.4 billion in 2021, then sank by 39.98% to $3.2 billion in 2022, then sank by 77.95% to $713.6 million in 2023, then plunged by 54.89% to $321.9 million in 2024, then slumped by 182.24% to -$264.7 million in 2025.
• The last three EBT figures came in at -$264.7 million (Q4 2025), $28.9 million (Q3 2025), and -$455.8 million (Q2 2025), per Business Quant data.

Peer Comparison